Client News
Filter by:
- Nov 12 2020 Retrophin Completes Acquisition of Orphan Technologies
- Nov 12 2020 VistaGen Reports Positive Preclinical Data Differentiating Mechanism of Action of PH94B from Risk-Ridden Benzodiazepines
- Nov 11 2020 Retrophin to Present at Upcoming Investor Conferences
- Nov 9 2020 VistaGen Therapeutics to Participate in the Guggenheim Healthcare Talks | Idea Forum | 2nd Annual Neuro/Immunology Day
- Nov 9 2020 BG Staffing, Inc. to Participate in the Virtual Southwest IDEAS Investor Conference
- Nov 5 2020 Retrophin Reports Third Quarter 2020 Financial Results
- Nov 5 2020 BG Staffing, Inc. Announces Third Quarter 2020 Financial Results
- Nov 2 2020 RETRANSMISSION: Emerald Health Therapeutics Completes Sale of Pure Sunfarms Interest and Achieves Pivotal Milestone in Transforming its Business
- Oct 22 2020 BG Staffing, Inc. to Host Fiscal 2020 Third Quarter Earnings Conference Call and Webcast
- Sep 22 2020 Q BioMed, Inc. CEO Discusses Recently Announced International Market Authorizations and Expansion in to South and Central America and Asia for Q BioMed’s Strontium89, its FDA Approved Drug for the Non-Opioid Treatment of Metastatic Cancer in the Bone